Skip to main content
SpringerLink
Log in

The Management of Peyronie’s Disease

  • Chapter
  • First Online:
Surgical Procedures for Core Urology Trainees

  • 882 Accesses

Abstract

Peyronie’s disease (PD) was first described by Francois de la Peyronie (1678–1747), who reported a series of patients with “rosary beads of scar tissue” causing curvature of the penis. Peyronie’s Disease is an acquired benign fibrotic disorder involving the tunica albuginea (TA) of the corpora cavernosa of the penis leading to the formation of fibrous inelastic plaques [1]. Peyronie’s Disease is believed to occur in the genetically susceptible individuals and is associated with penile curvature, pain and worsening of erectile function. Peyronie’s Disease has an estimated prevalence of 3–9% in adult men and is frequently associated with cardiovascular risk factors including diabetes, hypertension, dyslipidaemia, and low serum testosterone levels [2–5].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chung E, Ralph D, Kagioglu A, Garaffa G, Shamsodini A, Bivalacqua T, Glina S, Hakim L, Sadeghi-Nejad H, Broderick G. Evidence-based management guidelines on Peyronie’s disease. J Sex Med. 2016;13(6):905–23.

    Article  PubMed  Google Scholar 

  2. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie’s disease: results of a large survey. BJU Int. 2001;88:727–30.

    Article  CAS  PubMed  Google Scholar 

  3. Ralph DJ, Gonzalez-Cavadid N, Mirone V, Perovic S, Sohn M, Usta M, Levine L. The management of Peyronie’s disease: evidence-based 2010 guidelines. J Sex Med. 2010;7(7):2359–74.

    Article  PubMed  Google Scholar 

  4. Kendirci M, Trost L, Sikka SC, Hellstrom GJ. Diabetes mellitus is associated with severe Peyronie’s disease. BJU Int. 2007;99:383–6.

    Article  PubMed  Google Scholar 

  5. Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S. A retrospective review of 307 men with Peyronie’s disease. J Urol. 2002;68:1075–9.

    Google Scholar 

  6. Gelbard MK, Dorey F, James K. The natural history of Peyronie’s disease. J Urol. 1990;144:1376–9.

    Article  CAS  PubMed  Google Scholar 

  7. Nelson CJ, Diblasio C, Kendirci M, Hellstrom W, Guhring P, Mulhall JP. The chronology of depression and distress in men with Peyronie’s disease. J Sex Med. 2008;5:1985–90.

    Article  PubMed  Google Scholar 

  8. Gonzalez-Cadavid NF. Mechanisms of penile fibrosis. J Sex Med. 2009;6(Suppl 3):353–62.

    Article  PubMed  Google Scholar 

  9. Castiglione F, Hedlund P, Van der Aa F, Bivalacqua TJ, Rigatti P, Van Poppel H, Montorsi F, De Ridder D, Albersen M. Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie’s disease. Eur Urol. 2013;63(3):551–60.

    Article  CAS  PubMed  Google Scholar 

  10. Pryor J, Akkus E, Alter G, Jordan G, Lebret T, Levine L, Mulhall J, Perovic S, Ralph DJ, Stackl W. Peyronie’s disease. J Sex Med. 2004;1:110–5.

    Article  PubMed  Google Scholar 

  11. Bella AJ, Perelman MA, Brant WO, Lue TF. Peyronie’s disease (CME). J Sex Med. 2007;4:1527–38.

    Article  CAS  PubMed  Google Scholar 

  12. Wessells H, Lue TF, McAninch JW. Penile length in the flaccid and erect states: guidelines for penile augmentation. J Urol. 1996;156(3):995–7.

    Article  CAS  PubMed  Google Scholar 

  13. Levine LA, Greenfield JM. Establishing a standardized evaluation of the man with Peyronie’s disease. Int J Impot Res. 2003;15(Suppl 5):S103–12.

    Article  PubMed  Google Scholar 

  14. Pryor JP, Ralph DJ. Clinical presentations of Peyronie’s disease. Int J Impot Res. 2002;14:414–7.

    Article  CAS  PubMed  Google Scholar 

  15. Deveci S, Hopps C, O’Brien K, Parker M, Guhring P, Mulhall JP. Defining the clinical characteristics of Peyronie’s disease in young men. J Sex Med. 2007;4:485–90.

    Article  PubMed  Google Scholar 

  16. Joice GA, Burnett AL. Nonsurgical interventions for Peyronie’s disease: update as of 2016. World J Mens Health. 2016;34(2):65–72.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Zarafonetis CJD, Horrax TM. Treatment of Peyronie’s disease with potassium paraaminobenzoate (Potaba). J Urol. 1959;81:770–2.

    Article  CAS  PubMed  Google Scholar 

  18. Shah PJR, Green NA, Adib RS, et al. A multicentre doubleblind controlled clinical trial of potassium-para-aminobenzoate (Potaba) in Peyronie’s disease. Prog Reprod Biol Med. 1983;9:61–7.

    Google Scholar 

  19. Weidner W, Hauck EW, Schnitker J. Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie’s disease: a prospective, placebocontrolled, randomized study. Eur Urol. 2005;47:530–6.

    Article  CAS  PubMed  Google Scholar 

  20. Paulis G, Cavallini G, Brancato T, Alvaro R. Peironimev-Plus® in the treatment of chronic inflammation of tunica albuginea (Peyronie’s disease). results of a controlled study. Inflamm Allergy Drug Targets. 2013;12(1):61–7.

    Article  CAS  PubMed  Google Scholar 

  21. Pryor JP, Farell CR. Controlled clinical trial of vitamin E in Peyronie’s disease. Prog Reprod Biol Med. 1983;9:41–5.

    Google Scholar 

  22. Safarinejad MR, Hosseini SY, Kolahi AA. Comparison of vitamin E and propionyl-Lcarnitine, separately or in combination, in patients with early chronic Peyronie’s disease: a doubleblind, placebo controlled, randomized study. J Urol. 2007;178(4 Pt 1):1398–403.

    Article  CAS  PubMed  Google Scholar 

  23. Teloken C, Rhoden EL, Grazziotin TM, Ros CT, Sogari PR, Souto CA. Tamoxifen versus placebo in the treatment of Peyronie’s disease. J Urol. 1999;162:2003–5.

    Article  CAS  PubMed  Google Scholar 

  24. Akkus E, Carrier S, Rehman J, Breza J, Kadioglu A, Lue TF. Is colchicine effective in Peyronie’s disease? A pilot study. Urology. 1994;44:291–5.

    Article  CAS  PubMed  Google Scholar 

  25. Kadioglu A, Tefekli A, Köksal T, Usta M, Erol H. Treatment of Peyronie’s disease with oral colchicine: long-term results and predictive parameters of successful outcome. Int J Impot Res. 2000;12:169–75.

    Article  CAS  PubMed  Google Scholar 

  26. Safarinejad MR. Therapeutic effects of colchicine in the management of Peyronie’s disease: a randomized double-blind, placebo-controlled study. Int J Impot Res. 2004;16:238–43.

    Article  CAS  PubMed  Google Scholar 

  27. Prieto Castro RM, Leva Vallejo ME, Regueiro Lopez JC, Anglada Curado FJ, Alvarez Kindelan J, Requena Tapia MJ. Combined treatment with vitamin E and colchicine in the early stages of Peyronie’s disease. BJU Int. 2003;91:522–4.

    Article  CAS  PubMed  Google Scholar 

  28. Brant WO, Dean RC, Lue TF. Treatment of Peyronie’s disease with oral pentoxifylline. Nat Clin Pract Urol. 2006;3:111–5.

    Article  PubMed  Google Scholar 

  29. Smith JF, Shindel AW, Huang YC, Clavijo RI, Flechner L, Breyer BN, Eisenberg ML, Lue TF. Pentoxifylline treatment and penile calcifications in men with Peyronie’s disease. Asian J Androl. 2011;13(2):322–5.

    Article  CAS  PubMed  Google Scholar 

  30. Gonzalez-Cadavid NF, Rajfer J. Treatment of Peyronie’s disease with PDE5 inhibitors: an antifibrotic strategy. Nat Rev Urol. 2010;7:215–21.

    Article  CAS  PubMed  Google Scholar 

  31. Palmieri A, Imbimbo C, Creta M, Verze P, Fusco F, Mirone V. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial. Int J Androl. 2012;35:190–5.

    Article  CAS  PubMed  Google Scholar 

  32. Dell'Atti L. Tadalafil once daily and intralesional verapamil injection: a new therapeutic direction in Peyronie’s disease. Urol Ann. 2015;7:345–9.

    PubMed  PubMed Central  Google Scholar 

  33. Winter CC, Khanna R. Peyronie’s disease: results with dermo-jet injection of dexamethasone. J Urol. 1975;114:898–900.

    Article  CAS  PubMed  Google Scholar 

  34. Desanctis PN, Furey CA Jr. Steroid injection therapy for Peyronie’s disease: a 10-year summary and review of 38 cases. J Urol. 1967;97:114–6.

    Article  CAS  PubMed  Google Scholar 

  35. Toksu E. Peyronie’s disease: a method of treatment. J Urol. 1971;105:523–4.

    Article  CAS  PubMed  Google Scholar 

  36. Furey CA Jr. Peyronie’s disease: treatment by the local injection of meticortelone and hydrocortisone. J Urol. 1957;77:251–66l.

    Article  PubMed  Google Scholar 

  37. Cipollone G, Nicolai M, Mastroprimiano G, Iantorno R, Longeri D, Tenaglia R. Betamethasone versus placebo in Peyronie’s disease. Arch Ital Urol Androl. 1998;70:165–8.

    CAS  PubMed  Google Scholar 

  38. Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190:199–207.

    Article  CAS  PubMed  Google Scholar 

  39. Levine LA, Cuzin B, Mark S, Gelbard MK, Jones NA, Liu G, et al. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie’s disease: a phase 3 open-label study. J Sex Med. 2015;12:248–58.

    Article  PubMed  Google Scholar 

  40. Lipshultz LI, Goldstein I, Seftel AD, Kaufman GJ, Smith TM, Tursi JP, et al. Clinical efficacy of collagenase clostridium histolyticum in the treatment of Peyronie’s disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies. BJU Int. 2015;116:650–6.

    Article  CAS  PubMed  Google Scholar 

  41. US Food & Drug Administration (FDA). FDA approves drug treatment for Peyronie’s disease [Internet]. Silver Spring, MD: US FDA; 2013. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm377849.htm. Accessed 11 Aug 2016

    Google Scholar 

  42. Levine LA, Merrick PF, Lee RC. Intralesional verapamil injection for the treatment of Peyronie’s disease. J Urol. 1994;151:1522–4.

    Article  CAS  PubMed  Google Scholar 

  43. Levine LA. Treatment of Peyronie’s disease with intralesional verapamil injection. J Urol. 1997;158:1395–9.

    Article  CAS  PubMed  Google Scholar 

  44. Levine LA, Goldman K, Greenfield J. Experience with intraplaque injection of verapamil for Peyronie’s disease. J Urol. 2002;168:621–6.

    Article  CAS  PubMed  Google Scholar 

  45. Hellstrom WJ, Kendirci M, Matern R, et al. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie’s disease. J Urol. 2006;176:394–8.

    Article  CAS  PubMed  Google Scholar 

  46. Inal T, Tokatli Z, Akand M, Ozdiler E, Yaman O. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie’s disease: a randomized and prospective study. Urology. 2006;67:1038–42.

    Article  PubMed  Google Scholar 

  47. Fojecki GL, Tiessen S, Osther PJ. Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie’s disease, erectile dysfunction and chronic pelvic pain. World J Urol. 2016;

    Google Scholar 

  48. Hatzichristodoulou G, Meisner C, Gschwend JE, Stenzl A, Lahme S. Extracorporeal shock wave therapy in Peyronie’s disease: results of a placebo-controlled, prospective, randomized, single-blind study. J Sex Med. 2013;10:2815–21.

    Article  PubMed  Google Scholar 

  49. Gao L, Qian S, Tang Z, Li J, Yuan J. A meta-analysis of extracorporeal shock wave therapy for Peyronie’s disease. Int J Impot Res. 2016;

    Google Scholar 

  50. Riedl CR, Plas E, Engelhardt P, Daha K, Pflüger H. Iontophoresis for treatment of Peyronie’s disease. J Urol. 2000;163:95–9.

    Article  CAS  PubMed  Google Scholar 

  51. Di Stasi S, Giannantoni A, Stephen RL, et al. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie’s disease. J Urol. 2004;171:1605–8.

    Article  PubMed  Google Scholar 

  52. Greenfield JM, Shah SJ, Levine LA. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial. J Urol. 2007;177:972–5.

    Article  CAS  PubMed  Google Scholar 

  53. Li J, Duncan RL, Burr DB, Turner CH. L-Type calcium channels mediate mechanically induced bone formation in vivo. J Bone Miner Res. 2003;18:58–66.

    Article  CAS  PubMed  Google Scholar 

  54. Alman BA, Greel DA, Ruby LK, et al. Regulation of proliferation and platelet-derived growth factor expression in palmar fibromatosis (Dupuytren contracture) by mechanical strain. J Orthop Res. 1996;14:722–8.

    Article  CAS  PubMed  Google Scholar 

  55. Brighton CT, Fisher JRS Jr, Levine SE, et al. The biochemical pathway mediating the proliferative response of bone cells to a mechanical stimulus. J Bone Joint Surg Am. 1996;78:1337–47.

    Article  CAS  PubMed  Google Scholar 

  56. Levine LA, Newell M, Taylor FL. Penile traction therapy for treatment of Peyronie’s disease: a single-center pilot study. J Sex Med. 2008;5:1468–73.

    Article  PubMed  Google Scholar 

  57. Gontero P, Di Marco M, Giubilei G, et al. Use of penile extender device in the treatment of penile curvature as a result of Peyronie’s disease. Results of a phase II prospective study. J Sex Med. 2009;6:559–66.

    Article  Google Scholar 

  58. Kendirci M, Hellstrom WJ. Critical analysis of surgery for Peyronie’s disease. Curr Opin Urol. 2004;6:381–8.

    Article  Google Scholar 

  59. Dimitriou R, Levine LA. A surgical algorithm for penile prosthesis placement in men with erectile failure and Peyronie’s disease. J Urol. 1999;161:1014A.

    Google Scholar 

  60. Levine LA, Lenting E. A surgical algorithm for the treatment of Peyronie’s disease. J Urol. 1997;158:2149–52.

    Article  CAS  PubMed  Google Scholar 

  61. Ralph DJ, Minhas S. The management of Peyronie’s disease. BJU Int. 2004;93:208–15.

    Article  CAS  PubMed  Google Scholar 

  62. Nesbit RM. Congenital curvature of the phallus: report of three cases with description of corrective operation. J Urol. 1965;93:230–2.

    Article  CAS  PubMed  Google Scholar 

  63. Ralph DJ, al-Akraa M, Pryor JP. The Nesbit operation for Peyronie’s disease: 16-year experience. J Urol 1995; 4: 1362–1363.

    Google Scholar 

  64. Essed E, Schroeder F. New surgical technique for Peyronie’s disease. Urology. 1985;25:582–7.

    Article  CAS  PubMed  Google Scholar 

  65. Hauck E, Bschlaipfer T, Diemer T, Manning M, Schroeder-Printzen I, Weidner W. Long term results of Essed-Schroeder plication by the use of non absorbable Goretex sutures for correcting congenital penile curvature. Int J Impot Res. 2002;14(3):146–50.

    Article  CAS  PubMed  Google Scholar 

  66. Gholami SS, Lue TF. Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol. 2002;167:2066–9.

    Article  PubMed  Google Scholar 

  67. Taylor FL, Levine LA. Surgical correction of Peyronie’s disease using Tunica Albuginea plication or partial plaque excision with pericardial graft: long-term followup. J Sex Med. 2008;5:2221–8.

    Article  PubMed  Google Scholar 

  68. Yachia D. Modified corporoplasty for the treatment of penile curvature. J Urol. 1990;143:80–2.

    Article  CAS  PubMed  Google Scholar 

  69. Dalkin BL, Carter MF. Venogenic impotence following dermal graft repair for Peyronie’s disease. J Urol. 1991;146:849–51.

    Article  CAS  PubMed  Google Scholar 

  70. Gelbard MK. Relaxing incisions in the correction of penile deformity due to Peyronie’s disease. J Urol. 1995;154:1457–60.

    Article  CAS  PubMed  Google Scholar 

  71. Mulhall JP, Anderson M, Parker M. A surgical algorithm for men with combined Peyronie’s disease and erectile dysfunction: Functional and satisfaction outcomes. J Sex Med. 2005;2:132–8.

    Article  PubMed  Google Scholar 

  72. Kovac JR, Brock GB. Surgical outcomes and patient satisfaction after dermal, pericardial, and small intestinal submucosal grafting for Peyronie’s disease. J Sex Med. 2007;4:1500–8.

    Article  PubMed  Google Scholar 

  73. Leungwattanakij S, Bivalacqua TJ, Reddy S, Hellstrom WJ. Long-term follow-up on use of pericardial graft in the surgical management of Peyronie’s disease. Int J Impot Res. 2001;13:183–6.

    Article  CAS  PubMed  Google Scholar 

  74. Kadioglu A, Sanli O, Akman T, Ersay A, Guven S, Mammadov F. Grafts materials in Peyronie’s disease surgery: a comprehensive review. J Sex Med. 2007;4:581–95.

    Article  PubMed  Google Scholar 

  75. Brannigan RE, Kim ED, Oyasu R, McVary KT. Comparison of tunica albuginea substitute for the treatment of Peyronie’s disease. J Urol. 1998;159:1064–8.

    Article  CAS  PubMed  Google Scholar 

  76. El Sakka AI, Lue TF. Venous grafting for the correction of penile curvature in Peyronie’s disease. Curr Opin Urol. 1998;8(6):541–6.

    Article  PubMed  Google Scholar 

  77. Kadioglu A, Tfekli A, Usta M, Demirel S, Tallaloglu S. Surgical treatment of Peyronie’s disease with incision and venous patch technique. Int J Impot Res. 1999;11(2):75–81.

    Article  CAS  PubMed  Google Scholar 

  78. Arena F, Peracchia G, Di Stefano C, Barbieri A, Cortellini P. Peyronie’s disease: incision and dorsal vein grafting combined with contralateral plication in straightening the penis. Scand J Urol Nephrol. 1999;33(3):181–5.

    Article  CAS  PubMed  Google Scholar 

  79. Akkus E, Ozkara H, Alici B, Demirkesen O, Akaydin A, Hattat H, Solok V. Incision and venous patch graft in the surgical treatment of penile curvature in Peyornie’s disease. Eur Urol. 2001;40(5):531–6.

    Article  CAS  PubMed  Google Scholar 

  80. Adeniyi A, Goorney SR, Pryor JP, Ralph DJ. The Lue procedure: analysis of the outcome in Peyronie’s disease. BJU Int. 2002;89:404–8.

    Article  CAS  PubMed  Google Scholar 

  81. Levine LA, Estrada CR. Human cadaveric pericardial graft for the surgical correction of Peyronie’s disease. J Urol. 2003;170:2359–62.

    Article  PubMed  Google Scholar 

  82. Montorsi F, Salonia A, Briganti A, Dehò F, Zanni G, Luigi DP, Rigatti P. Five year follow up of plaque incision and vein grafting for Peyronie’s disease [Abst 1256]. Annual meeting of the American Urological Association; 2004.

    Google Scholar 

  83. Kalsi J, Minhas S, Christopher N, Ralph D. The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie’s disease. BJU Int. 2005;95:1029–33.

    Article  PubMed  Google Scholar 

  84. Shioshvili TJ, Kakonashvili AP. The surgical treatment of Peyronie’s disease: replacement of plaque with free autograft of buccal mucosa. Eur Urol. 2005;48(1):129–33.

    Article  PubMed  Google Scholar 

  85. Kalsi J, Cristopher AN, Ralph DJ, Minhas S. Plaque incision and fascia lata grafting in the surgical management of Peyronie’s disease. BJU Int. 2006;98(1):110–4.

    Article  PubMed  Google Scholar 

  86. Cormio L, Zucchi A, Lorusso F, Selvaggio O, Fioretti F, Porena M, Carrieri G. Surgical treatment of Peyronie’s disease by plaque incision and grafting with buccal mucosa. Eur Urol. 2009;55(6):1479–65.

    Article  Google Scholar 

  87. Egydio PH, Lucon AM, Arap S. Treatment of Peyronie’s disease by incomplete circumferential incession of the tunica albuginea and plaque with bovine pericardium graft. Urology. 2002;59:570–4.

    Article  PubMed  Google Scholar 

  88. Sansalone S, Garaffa G, Djinovic R, Pecoraro S, Silvani M, Barbagli G, Zucchi A, Vespasiani G, Loreto C. Long-term results of the surgical treatment of Peyronie’s disease with the Egydio’s technique: a European multicentre study. Asian J Androl. 2011;13(6):842–6.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Levine LA, Greenfield JM, Estrada CR. Erectile dysfunction following surgical correction of Peyronie’s disease and a pilot study of the use of Sildenafil citrate rehabilitation for postoperative erectile dysfunction. J Sex Med. 2007;5:241–7.

    Google Scholar 

  90. Garaffa G, Minervini A, Christopher NA, Minhas S, Ralph DJ. The management of residual curvature after penile prosthesis implantation in men with Peyronie’s disease. BJU Int. 2011;108(7):1152–6.

    Article  PubMed  Google Scholar 

  91. Bonillo MA, Garaffa G, Ralph DJ. Addressing residual penile deformity in the Peyronie’s disease patient during penile implant surgery. Curr Sex Health Rep. 2007;4(4):163–6.

    Article  Google Scholar 

  92. Wilson SK, Carson CC. Surgical straightening with penile prosthesis. In: Levine L, editor. Peyronie’s disease. a guide to clinical management. Totowa, NJ: Humana; 2007. p. 249–58.

    Google Scholar 

  93. Wilson SK, Delk JR. A new treatment for Peyronie’s disease: modelling the penis over an inflatable penile prosthesis. J Urol. 1994;152:1121–3.

    Article  CAS  PubMed  Google Scholar 

  94. Wilson SK, Cleves MA, Delk JR II. Long term follow up of treatment for Peyronie’s disease: modeling the penis over an inflatable penile prosthesis. J Urol. 2001;165:825–9.

    Article  CAS  PubMed  Google Scholar 

  95. Kovalczyk JJ, Mulcahy JJ. Penile curvatures and aneurysmal defects with the Ultrex penile prosthesis corrected with the insertion of AMS 700 CX. J Urol. 2001;165:825–9.

    Article  Google Scholar 

  96. Chung E, Solomon M, De Young L, Brock GB. Comparison between AMS 700 CX and coloplast titan inflatable penile prosthesis for Peyronie’s disease treatment and remodelling: clinical outcomes and patients satisfaction. J Sex Med. 2013;10(11):2855–60.

    Article  PubMed  Google Scholar 

  97. Levine LA, Dimitriou RJ. A surgical algorithm for penile prosthesis placement in men with erectile failure and Peyronie’s disease. Int J Impot Res. 2000;12:147–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, The Institute of Urology, University College London Hospitals, 16-18 Westmoreland Street, W1G 8PH, London, UK

    Fabio Castiglione M.D., Ph.D., David J. Ralph F.R.C.S. (Urol) & Giulio Garaffa M.D., Ph.D., F.R.C.S.

Authors
  1. Fabio Castiglione M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David J. Ralph F.R.C.S. (Urol)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giulio Garaffa M.D., Ph.D., F.R.C.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. East of England Deanery, Princess Alexandra Hospital, Harlow, United Kingdom

    Sanchia Goonewardene

  2. Southmead Hospital, North Bristol NHS Trust, Bristol, United Kingdom

    Raj Persad

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Castiglione, F., Ralph, D.J., Garaffa, G. (2018). The Management of Peyronie’s Disease. In: Goonewardene, S., Persad, R. (eds) Surgical Procedures for Core Urology Trainees. Springer, Cham. https://doi.org/10.1007/978-3-319-57442-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-57442-4_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-57441-7

  • Online ISBN: 978-3-319-57442-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation